BioCentury | Jan 8, 2021
Deals
Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more
...participation from new investors Solasta Ventures and Livzon Pharmaceutical Group Inc. Existing investors AbbVie Ventures, HealthCap...
...Venture Abingworth Kira Pharmaceuticals RA Capital Management Vivo Capital Foresite Capital Qiming Venture Partners Carisma Therapeutics Inc. SymBiosis LLC Solasta Ventures Livzon Pharmaceutical Group Inc. AbbVie Ventures HealthCap Wellington...
...Venture Abingworth Kira Pharmaceuticals RA Capital Management Vivo Capital Foresite Capital Qiming Venture Partners Carisma Therapeutics Inc. SymBiosis LLC Solasta Ventures Livzon Pharmaceutical Group Inc. AbbVie Ventures HealthCap Wellington...